Heart attacks and strokes are among the leading causes of death globally, with millions suffering from cardiovascular diseases (CVD) every year. There are more than seven million people in the UK alone, with about 100,000 patients experiencing heart attacks annually. However, a group of researchers at University College London (UCL) estimate that one 'polypill' taken daily day could eliminate a majority of these cases dramatically lowering death tolls.

The proposed polypill, a combination of a statin and three blood pressure-lowering drugs, has been under study for over two decades. Experts argue that introducing this pill universally for individuals aged 50 and above could be more effective than the current NHS Health Check, which assesses risk factors every five years for those aged between 40 and 74.

Studies have repeatedly proven the effectiveness of the polypill in preventing CVD. A groundbreaking 2019 study in The Lancet found that five years' use of the polypill cut the risk of heart attack and stroke by a third. In addition, previous modelling analyses have estimated that if given universally to people over 55, the polypill might be able to prevent 80% of heart attacks and strokes.

Today, the NHS Health Check follows a risk-based model in which patients are tested for CVD risk factors and treated with drugs accordingly. Yet, as per UCL's study, this system has serious flaws:

Low Uptake: Just 40% of those eligible for the NHS Health Check choose to have it, leaving a considerable number of at-risk patients undiagnosed and untreated.

Ineffective Prediction of Risk: The majority of heart attacks and strokes happen to people at average risk levels, thus making it challenging to identify the need for intervention effectively.

Limited Effectiveness: Even at maximum take-up, the NHS Health Check programme is predicted to have fewer health impacts compared to a polypill initiative applied to the whole population.

Simplicity and Affordability of the Polypill Strategy

One of the big benefits of the polypill is that it is so easy. In contrast to the existing screening-based model, the polypill scheme would not involve complicated medical tests or lengthy risk assessments. Instead, people reaching 50 would just have to fill out a few questions to determine possible side effects before they were prescribed.

Professor Aroon Hingorani of the UCL Institute of Cardiovascular Science, one of the strongest proponents of this scheme, says:

"Finally, the time is now to do much better on prevention. A population approach would prevent a lot more heart attacks and strokes than is done today with a strategy of trying to target a smaller group only."

Aside from the possible health implications, the polypill is also an economic solution. The drugs used are off-patent, thus cheap to produce and distribute. With the vast economic cost of managing CVD-related illnesses, a preventive model could result in substantial cost-saving for the NHS in the future.

The polypill has been proven to be effective by numerous international trials. In 2019, a randomised trial in rural Iran discovered that participants who took the polypill for five years had a 34% reduced risk of having a heart attack or stroke compared to non-participants.

Likewise, modelling research has indicated that even if only 8% of people aged over 50 took up the polypill regimen, it would still be more beneficial to their health than the NHS Health Check programme.

Is This a Case of Over-Medicalisation?

One of the main objections to the polypill strategy is the suggestion that it might result in the unnecessary medicalisation of a significant proportion of the population. But, it is argued, it should be considered as a preventative measure, not as mass medication.

Professor Sir Nicholas Wald of UCL's Institute of Health Informatics explains:

"Instead of being a 'medicalisation' of a significant proportion of the population, a polypill programme is a prevention measure to prevent an individual from becoming a patient."

He compares it with public health measures like water fluoridation or compulsory seatbelts—interventions that have been shown to have a significant impact in reducing public health danger at low individual cost.

With the evidence in favour of the polypill's effectiveness and viability overwhelming, experts are calling on the NHS to act now. It is their belief that substituting the NHS Health Check with a polypill-based prevention program could be the UK government's flagship policy under its pledge to put disease prevention ahead of cure.

As Professor Hingorani points out, "The status quo is not a justifiable option." With CVD still a major cause of death globally, taking a population-wide polypill approach could be a turning point for preventative medicine, potentially saving thousands of lives annually. The question now is whether the NHS will take up this call and establish a policy with the potential to transform the prevention of cardiovascular disease on a national level.

India is witnessing a concerning change in health patterns. Conditions like diabetes, cardiovascular disease, and certain cancers are appearing in higher numbers and at younger ages than in previous generations. While lifestyle factors like diet, stress, and reduced physical activity play a role, there is a deeper, often overlooked driver: genetics.

Dr Ramesh Menon, Director of Personal Genomics and Genomic Medicine, MedGenome, said, "From the discovery of DNA's double helix in 1953 to the completion of the Human Genome Project in 2003, today genomics, the study of our DNA, is helping us uncover these disease risks. Instead of studying DNA in isolation, scientists are using it to understand human health and disease. Why does one person develop cancer while another does not? Why are some people affected by Alzheimer’s early in life? Why do some people respond well to a drug while others experience severe side effects? Genomics is providing answers that matter."

Doctors can now identify genetic mutations linked to conditions like breast cancer, cystic fibrosis, or rare inherited disorders. In some cases, treatments are tailored to a patient’s genetic profile, a concept known as precision medicine. It is also helping reveal how inherited traits can interact with environmental factors to accelerate disease onset, helping identify risks early, enable timely screening, and tailor treatments more precisely. This DNA Day, we turn the spotlight on how understanding our genetics could be key to managing this early disease burden.

Why Indians Are Biologically More Vulnerable

Dr Menon said that studies suggest that Indians carry distinct genetic traits that may increase the chances of early onset of diseases. For instance, South Asians are more prone to insulin resistance and tend to develop Type 2 diabetes at a younger age compared to many Western populations. India is already home to over 100 million people living with diabetes, and that number is expected to rise sharply in the coming decades.

Another example is coronary artery disease, which tends to manifest nearly a decade earlier in Indians compared to many Western populations. Genetic variants affect cholesterol transport, inflammation, and arterial wall function, contributing to a higher risk, even among people who may seem to have healthy lifestyles. Similarly, certain cancers, such as breast and colorectal cancers, are increasingly being diagnosed earlier in Indian populations. Inherited genetic mutations linked to cell growth regulation and DNA repair, combined with environmental exposures, can increase the pace of tumour development.

What is more concerning is that a significant proportion of the population remains undiagnosed or is diagnosed at late stages, allowing diseases to progress silently.

The Sudden Lifestyle Flip

Dr Menon explained that just a generation ago, daily life involved far more physical movement, such as walking to work, manual labour, home-cooked meals, and limited access to processed food. Today, most of our routines are reversed. Desk jobs, high screen time, food and grocery delivery at the doorstep, and screen-heavy lifestyles mean many people burn fewer calories while consuming more energy-dense, ultra-processed foods. This imbalance is a key driver behind the increased rate of conditions such as cardiometabolic disorders and cancers.

What is striking is not just the increase in cases but also the decrease in the average age of disease onset. This is especially relevant for what many experts describe as an “F1 generation exposure." Our parents may not have lived with the same levels of inactivity or dietary change. Our genes, however, remain the same. The mismatch between genetic predisposition and rapid lifestyle shifts is where the problem intensifies.

Closing the Gap

In many Indian households, conditions like diabetes or heart disease are spoken about casually. “It runs in the family” is often said and quickly brushed aside. But genetics is not just about inherited risk. It also influences how early that risk shows up. If previous generations developed these conditions in their 50s and 60s, the timeline is now becoming shorter. That shift is subtle, but it is already playing out across India.

Perhaps the most critical gap lies in how we approach prevention. Indians are known to develop certain diseases nearly 8 to 10 years earlier than many Western populations, yet screening timelines often remain unchanged. Most people still begin serious health check-ups in their 40s. By then, metabolic changes may have been progressing quietly for years. The idea that a 30-year-old could already be at risk is still not widely accepted, even though the evidence increasingly suggests otherwise.

The larger shift we need is not just in how we treat disease but in how we anticipate it. Advances in genetic testing and preventive diagnostics now make it possible to identify risk much earlier and act before conditions fully develop. However, awareness remains the missing link. Moreover, health conversations in families are still reactive, not proactive. Something as simple as knowing when a parent was diagnosed or what conditions are common in the family can offer valuable insight into one’s own risk.

World Malaria Day is observed on April 25 every year to raise awareness of the infection, its causes, symptoms, and prevention strategies. At a time when the heatwave is at its most severe, many fall victim to the misconception that rising temperatures could mitigate infection risk. However, according to Dr Anil Ballani, Consulting Physician in Internal Medicine at Lilavati Hospital and Research Centre, this is just a myth.

What is malaria?

Malaria is a disease transmitted by mosquitoes, mainly female Anopheles mosquitoes, which transmit parasites of the genus Plasmodium. The term ‘malaria’ is derived from the Italian words “ma laria”, which translates to ‘bad air’. Malaria remains one of the major health problems in India, even though the incidence rate has been brought down from 33 million to 3.2 million in the last three decades.

Is malaria only a monsoon concern?

On World Malaria Day, Dr Ballani explained that, contrary to popular belief, malaria is not just a concern during the monsoon season. Unfortunately, it can occur in summer as well. It is well known that malaria incidence is highest during the rainy season due to stagnant water. However, surprisingly, there is also a surge in malaria cases during the summer season. The hot days of summer act as a precursor, as the warm temperature accelerates mosquito breeding. Also, people tend to store water in drums and buckets during the summer due to shortages, and these serve as perfect breeding grounds for mosquitoes.

High temperatures in summer accelerate the mosquito life cycle and maturation, resulting in increased multiplication of larvae. High humidity and high temperatures in summer create ideal conditions for the mosquito life cycle. Faster maturation of the parasite in the mosquito leads to the rapid spread of malaria. Consequently, the risk of malaria transmission also increases. There is often poor vector control prior to the monsoon, as fumigation usually starts after the monsoon sets in.

What makes children vulnerable to malaria?

Schools are closed during the summer, and children venture out more to play. People spend more time in gardens and parks during the early hours of the day and in the evenings due to cooler temperatures, and all this increases their risk of exposure to mosquito bites. Many people travel to their hometowns and villages during holidays when schools are closed, where the incidence of malaria is higher. Due to warm weather, people avoid wearing full sleeves and long clothing, resulting in greater exposure of the arms and legs and increasing the risk of mosquito bites. All these are precursors to a high incidence of malaria in the summer months.

Can malaria diagnosis be delayed?

On World Malaria Day, Dr Ballani answered an important question - can malaria diagnosis be delayed? The expert said that sometimes doctors may delay the diagnosis of malaria because of low suspicion during the summer months. Hence, for proper diagnosis, doctors must maintain a high index of suspicion even during summer months and remain vigilant throughout the year. India aims to eliminate malaria by the year 2030, as guided by the National Framework for Malaria Elimination (NFME), and measures such as maintaining a high index of suspicion will go a long way in making this a reality.

From polio to measles, vaccines have remained one of the most powerful tools in public health, saving six lives every minute, according to the World Health Organization (WHO), as it marked World Immunization Week today.

World Immunization Week is observed every year from April 24 to April 30 to raise awareness about the importance of vaccines for saving lives.

Also Read: Depressed After A Failed IVF? Be Warned, Restrictive Behaviour May Not Help You Later

According to the WHO, vaccines have saved more than 150 million lives over the past 50 years.

"That’s 6 lives every minute, every day, for more than 5 decades," the WHO said.

These lives were saved "not by accident, but because ordinary people made the decision to protect themselves, their children, and their communities from diseases like measles, diphtheria, pertussis, polio, and rotavirus".

Currently, more than 30 life-threatening diseases and infections are prevented by vaccines.

However, 20 million children missed at least one vaccine dose in 2024, leaving far too many at risk of preventable disease.

"Today, newer vaccines against malaria, HPV, cholera, dengue, meningitis, RSV, Ebola, and mpox are saving even more lives, and helping people at every stage of life live longer and healthier thanks to scientific advancements," the WHO added.

Also Read: Delhi Wakes Up To The Hottest Day In 2026 Amid Heatwave; IMD Issues Alert

World Immunization Week: Origin

World Immunization Week was officially endorsed by the World Health Assembly in May 2012 to unify regional vaccination efforts into a single global campaign. Before 2012, it was observed on different days in different countries.

World Immunization Week 2026: Theme

The theme this year is “For every generation, vaccines work”. It promotes how vaccines have safely protected people, families, and communities for generations.

It also calls on countries to sustain and expand vaccination coverage at every age, to safeguard the future.

As the world is at the midpoint of the Immunization Agenda 2030, the priority remains reaching zero-dose children and advancing equity in the hardest-to-reach communities, particularly in countries grappling with conflict, instability, or fragile health systems, the WHO said.

World Immunization Week: The Big Catch-Up

The Big Catch-Up, a campaign launched during World Immunization Week 2023, has been a multi-country effort to address vaccination declines driven largely by the COVID-19 pandemic.

The campaign has delivered over 100 million vaccine doses to an estimated 18.3 million children aged 1 to 5 across 36 countries.

Around 12.3 million were “zero-dose children” who had not previously received any vaccines, and 15 million who had never received a measles vaccine.

The initiative concluded in March 2026 and is on track to meet its target of vaccinating up to 21 million children.

However, agencies like Gavi, the Vaccine Alliance (Gavi), WHO, and UNICEF warn that many infants still miss out on lifesaving vaccines through routine immunization every year.

"By protecting children who missed out on vaccinations because of disruptions to health services caused by COVID-19, the Big Catch-Up has helped to undo one of the pandemic's major negative consequences," said Dr Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization.

In 2024, an estimated 14.3 million infants under the age of one globally failed to receive a single vaccine through routine immunization programmes.

The WHO noted that the global resurgence of measles is a consequence of chronic gaps in routine immunisation.

Measles outbreaks are rising across continents — from Europe to Africa to North America to Australia.

"This surge is driven by persistent gaps in measles vaccination through routine immunization programmes, compounded by declining vaccine confidence in some previously high-coverage communities," the WHO said.